Targeted doxorubicin-liposomes as a tool to circumvent P-gp-mediated resistance in ovarian carcinoma cells.
Krieger
M L
ML
Department of Pharmacy, University of Bonn, Bonn, Germany. mkrieger@uni-bonn.de
Konold
A
A
Wiese
M
M
Jaehde
U
U
Bendas
G
G
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000502:physiology*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000008:administration & dosage*; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008081:Liposomes; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D008081:Liposomes; D004317:Doxorubicin